TNBC (HR- HER2-) Neoadjuvant

HIGH RISKALTERNATEALTERNATEALTERNATESTARTFINISHCreated with SnapHR negativeHER2 negative(TNBC)STARTFINISHCreated with SnapPembrolizumab incombination withsequential Paclitaxelplus Carboplatin andanthracycline (EC)PCRNON PCRBRCA +VESTARTFINISHCreated with SnapSurgerySTARTFINISHCreated with SnapConsider adjuvantpembrolizumab (onlyif prior neo-adjuvantpembrolizumab)STARTFINISHCreated with SnapConsider eitheradjuvant capecitabineor pembrolizumab(only if priorneo-adjuvant...STARTFINISHCreated with SnapConsider adjuvantolaparibSTARTFINISHCreated with SnapSequentialanthracycline (EC)and taxane (Paclitaxelor Docetaxel)STARTFINISHCreated with SnapDocetaxel andCarboplatinPCRNON PCRBRCA +VESTARTFINISHCreated with SnapSurgerySTARTFINISHCreated with SnapFollow upSTARTFINISHCreated with SnapConsider adjuvantCapecitabineSTARTFINISHCreated with SnapConsider adjuvantolaparibSTARTFINISHCreated with SnapDocetaxel andCyclophosphamideSTARTFINISHCreated with SnapEpirubicin andCyclophosphamide